GodelTech is providing and developing advanced middleware to Chimatica that enables powerful bioinformatic, computational chemistry and modelling simulations in the form of flexible workflows to be designed and executed using massively parallel computing resources. Harnessing the scalability of such a system enables Chimatica to reduce end to end computationally intensive tasks from weeks to hours or minutes, and greatly increases the amount of testing and knowledge inherent in drug candidate design projects in ways not currently possible elsewhere.

In close cooperation with Chimatica engineers and drug designers, and a team of scientists at the University of Manchester Department of Computer Science, Godeltech has designed the technical architecture of the solution and delivering it’s implementation through the services of a dedicated team of high quality software engineers.

Chimatica offers best in class in silico drug design services and biological screening candidates to the pharmaceutical, biotechnology and chemical industries.

“We are delighted with the speed of progress made by GodelTech in helping to deliver key technical objectives in our mission to provide the highest calibre drug prototypes to our clients and reduce the time to market for new remedies to diseases. GodelTech is a great team to work with, very open to communication and technically excellent. We look forward to the outcomes and to extending our valued partnership over the coming months and years.” Dr Dominic Szewczyk, CEO, Chimatica Ltd.

“We are delighted to be working with Chimatica on such an advanced project and look forward to a very productive long term relationship.” Terry Bland, Managing Director, GodelTech.

GodelTech. is a leading provider of high quality software development services for businesses in the UK, Europe and North America. Headquarters in Manchester, UK, with development centres in Europe.

If you need further information or interested in partnership with GodelTech please get in touch.